Increasing trends of gonorrhoea and syphilis and the threat of drug-resistant gonorrhoea in Europe

Eurosurveillance

Volumn 17, Issue 29, 2012, Pages

  Van de Laar, M ^a   Spiteri, G ^a  

^a EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CEFIXIME; CEFTRIAXONE;

ADULTHOOD; ANTIBIOTIC RESISTANCE; CHLAMYDIASIS; DRUG SURVEILLANCE PROGRAM; DRUG TREATMENT FAILURE; EDITORIAL; EUROPE; GONORRHEA; HETEROSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFECTION RISK; MALE HOMOSEXUAL; MIXED INFECTION; NEISSERIA GONORRHOEAE; NUCLEIC ACID AMPLIFICATION; PRACTICE GUIDELINE; SINGLE DRUG DOSE; SYPHILIS; UNSAFE SEX;

EID: 84866417489     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Editorial

References (22)

1. European Centre for Disease Prevention and Control (ECDC). Sexually transmitted infections in Europe 1990-2010. Stockholm: ECDC; 2012. Available from: http://www.ecdc. europa.eu/en/publications/Publications/201206-Sexually-Transmitted-Infections-Europe-2010.pdf
2. Health protection Agency (HPA). Gonococcal Resistance to Antimicrobials Surveillance Programme in England and Wales (GRASP) report of 2010 data. Health Protection Report. 2011;5(37). Available from: http://www.hpa.org.uk/hpr/archives/2011/hpr3711.pdf
3. European Centre for Disease Prevention and Control (ECDC). Gonococcal antimicrobial susceptibility surveillance in Europe-2010. Stockholm: ECDC; 2012. Available from: http://ecdc. europa.eu/en/publications/Publications/1206-Gonococcal-AMR.pdf
4. Bremer V, Marcus U, Hamouda O. Syphilis on the rise again in Germany-results from surveillance data for 2011. Euro Surveill. 2012;17(29):pii=20222. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20222
5. Velicko I, Unemo M. Recent trends in gonorrhoea and syphilis epidemiology in Sweden: 2007 to 2011. Euro Surveill. 2012;17(29):pii=20223. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=20223
6. Savage EJ, Marsh K, Duffell S, Ison CA, Zaman A, Hughes G. Rapid increase in gonorrhoea and syphilis diagnoses in England in 2011. Euro Surveill. 2012;17(29):pii=20224. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20224
7. Bignell C, IUSTI/WHO. 2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS. 2009;20(7):453-7.
8. World Health Organisation (WHO). Global Action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. Geneva: WHO; 2012. Available from: http://whqlibdoc.who.int/publications/2012/9789241503501_eng.pdf
9. European Centre for Disease Prevention and Control (ECDC). Response plan to control and manage the threat of multidrug resistant gonorrhoea in Europe. Stockholm: ECDC; 2012. Available from: http://ecdc.europa.eu/en/publications/Publications/1206-ECDC-MDR-gonorrhoea-response-plan.pdf
10. Akasaka S, Muratani T, Yamada Y, Inatomi H, Takahashi K, Matsumoto T. Emergence of cephem-and aztreonam-highresistant Neisseria gonorrhoeae that does not produce betalactamase. J Infect Chemother. 2001;7(1):49-50.
11. Tapsall JW. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins. Curr Opin Infect Dis. 2009 Feb;22(1):87-91.
12. Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill. 2010;15(47):pii=19721. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=19721
13. Ison CA, Hussey J, Sankar KN, Evans J, Alexander S. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill. 2011;16(14):pii=19833. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=19833
14. Forsyth S, Penney P, Rooney G. Cefixime-resistant Neisseria gonorrhoeae in the UK: a time to reflect on practice and recommendations. Int J STD AIDS. 2011;22(5):296-7.
15. Unemo M, Golparian D, Stary A, Eigentler A. First Neisseria Gonorrhoeae Strain With Resistance to Cefixime Causing Gonorrhoea Treatment Failure in Austria. Euro Surveill. 2011;16(43):pii=19998. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19998
16. Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother. 2011;55(7):3538-45.
17. Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill. 2011;16(6):pii=19792. Available from: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=19792
18. Unemo M, Golparian D, Potocnik M, Jeverica S. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill. 2012;17(25):pii=20200. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=20200
19. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime-and ceftriaxone-resistant N. gonorrhoeae in Europe (France): novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother. 2012;56(3):1273-80.
20. Carnicer-Pont D, Smithson A, Fina-Homar E, Bastida MT. First cases of Neisseria gonorrhoeae resistant to ceftriaxone in Catalonia, Spain, May 2011. Enferm Infecc Microbiol Clin. 2012;30(4):218-9.
21. Cole MJ, Unemo M, Hoffmann S, Chisholm SA, Ison CA, van de Laar MJ. The European gonococcal antimicrobial surveillance programme, 2009. Euro Surveill. 2011;16(42):pii=19995. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=19995
22. Monfort L, Caro V, Devaux Z, Delannoy AS, Brisse S, Sednaoui P. First neisseria gonorrhoeae genotyping analysis in france: identification of a strain cluster with reduced susceptibility to Ceftriaxone. J Clin Microbiol. 2009;47(11):3540-5.